Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2025

Mar 18, 2025

29871_dirs_2025-03-18_59cd6679-14d2-40e0-b5be-aebb8d7f4489.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2025-03-15

Reporting Person: Sprague Suzanne (COO & Global Head of Clearing)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-15 Common Stock Class A A 345 $258.68 Acquired 8381 Direct
2025-03-15 Common Stock Class A F 153 $258.68 Disposed 8228 Direct
2025-03-15 Common Stock Class A A 1108 $258.68 Acquired 9336 Direct
2025-03-15 Common Stock Class A F 491 $258.68 Disposed 8845 Direct
2025-03-15 Common Stock Class A F 78 $258.68 Disposed 8767 Direct

Footnotes

F1: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.

F2: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.

F3: Represents shares earned from a March 2022 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.

F4: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2025.